AMPHIVENA THERAPEUTICS
Amphivena Therapeutics is a clinical-stage immuno-oncology company that develops a platform of dual-function biologics. Its Amphivena ReSTORE platform provides dual-action biologics that relieve immune suppression and activate T cell effector function in cancer patients. The platform design integrates elements of avidity, target selectivity, and enhanced safety within a single molecule. It is also can be engineered with additional solid tumor targeting modalities to add functionality such as directed tumor cell killing. It was founded in 2012 and is headquartered in South San Francisco, California.
AMPHIVENA THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Oncology Therapeutics
Founded:
2012-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.amphivena.com
Total Employee:
11+
Status:
Active
Contact:
415-994-6455
Email Addresses:
[email protected]
Total Funding:
135.69 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving WordPress Google Maps SSL By Default HSTS IPv6 Cloudflare Hosting Sitelinks Search Box
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Forty Seven
Forty Seven is a clinical-stage immuno-oncology company that is developing therapies targeting cancer immune evasion pathways.
Gritstone Bio
Gritstone Oncology is a clinical-stage biotech company that develops tumor-specific cancer immunotherapies to fight multiple cancer types.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Vor Biopharma
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.
Current Advisors List
Current Employees Featured
Founder
Investors List
Qiming Venture Partners
Qiming Venture Partners investment in Series C - Amphivena Therapeutics
+ND Capital
+ND Capital investment in Series C - Amphivena Therapeutics
Industrial Investors Group
Industrial Investors Group investment in Series C - Amphivena Therapeutics
Solasta Ventures
Solasta Ventures investment in Series C - Amphivena Therapeutics
Clough Capital Partners
Clough Capital Partners investment in Series C - Amphivena Therapeutics
Franklin Berger
Franklin Berger investment in Series C - Amphivena Therapeutics
Newton Investment Management
Newton Investment Management investment in Series C - Amphivena Therapeutics
Mérieux Equity Partners
Mérieux Equity Partners investment in Series C - Amphivena Therapeutics
Aju IB Investment
Aju IB Investment investment in Series C - Amphivena Therapeutics
MPM Capital
MPM Capital investment in Series C - Amphivena Therapeutics
Key Employee Changes
Date | New article |
---|---|
2019-12-02 | Amphivena Therapeutics appoints president and CEO |
Official Site Inspections
http://www.amphivena.com
- Host name: 104.21.43.46
- IP address: 104.21.43.46
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Amphivena Therapeutics"
Amphivena Therapeutics - Crunchbase Company …
Amphivena Therapeutics is a clinical-stage immuno-oncology company that develops a platform of dual-function biologics. Its Amphivena ReSTORE …See details»
Amphivena Therapeutics Company Profile 2024: …
Nov 21, 2017 Amphivena Therapeutics was founded in 2012. Where is Amphivena Therapeutics headquartered? Amphivena Therapeutics is …See details»
Amphivena Therapeutics Inc - LinkedIn
Amphivena Therapeutics is a clinical-stage immuno-oncology company that develops a platform of dual-function biologics. Its Amphivena ReSTORE platform provides dual-action biologics …See details»
Amphivena Therapeutics - Funding, Financials, Valuation & Investors
Amphivena Therapeutics is funded by 14 investors. Qiming Venture Partners and +ND Capital are the most recent investors. Amphivena Therapeutics has a post-money valuation in the range …See details»
Amphivena Therapeutics - Contacts, Employees, Board Members, …
Organization. Amphivena Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... About. Amphivena Therapeutics has 3 current employee …See details»
Amphivena Therapeutics, Inc. - Drug pipelines, Patents, Clinical …
Explore Amphivena Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, 7 news, and 11 literature, Drug:AMV300, AMV900, AMV600, …See details»
Amphivena Therapeutics - Craft
Amphivena Presents Translational Data Highlighting the Cytokine Profile for its Lead Clinical Candidate, AMV564 at the AACR 2021 Virtual Annual Meeting. Apr 12, 2021. Amphivena …See details»
Amphivena Therapeutics (USA) Funding: $135.7M
Nov 7, 2024 USA | Funding: $135.7M Website: http://amphivena.com/ Amphivena Therapeutics develops treatments to address hematologic malignancies.See details»
Amphivena Therapeutics, Inc. Details
Amphivena Therapeutics, Inc. is a clinical stage, immuno oncology company with a novel platform of T cell engagers (Amphivena ReSTORE™) that directly targets myeloid derived suppressor …See details»
Amphivena Therapeutics, Inc. (Amphivena Therapeutics, Inc.) - 药 …
了解Amphivena Therapeutics, Inc. (Amphivena Therapeutics, Inc.)公司的药物管线,治疗领域,技术平台,以及它的3项临床试验, 9篇新闻和2篇文献,药 …See details»
Amphivena Therapeutics | VentureRadar
Amphivena Therapeutics, in collaboration with Affimed AG, is developing bispecific TandAbs for hematologic malignancies. TandAbs are tetravalent bispecific antibody formats (~100kD) that …See details»
Amphivena Therapeutics - Tech Stack, Apps, Patents & Trademarks
Amphivena Therapeutics uses 14 technology products and services including HTML5, Modernizr, and Office 365, according to G2 Stack. Amphivena Therapeutics is actively using 9 …See details»
Amphivena Therapeutics, Inc. | CipherBio
Explore Amphivena Therapeutics, Inc.'s investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
AMV300 - Drug Targets, Indications, Patents - Synapse
AMV300, Initially developed by Amphivena Therapeutics, Inc., Now, its global highest R&D status is Pending, Therapeutic Areas: Neoplasms.See details»
Amphivena Presents New Monotherapy and First Combination …
Jun 4, 2021 Amphivena has raised $88.5 M to date in Series A, B and C venture financings led by NanoDimension, Qiming Venture Partners USA, MPM Capital and funds managed by Tekla …See details»
Amphivena Therapeutics - Crunchbase
Amphivena Therapeutics is a clinical-stage immuno-oncology company that develops a platform of dual-function biologics. Search Crunchbase. ... Solutions. Products. Resources. Pricing. …See details»
Amphivena closes $62m Series C financing to expand clinical …
Amphivena Therapeutics, Inc., a private clinical stage immuno-oncology company developing T cell engager therapeutics for cancer, announced today the closing of a $62 million Series C …See details»
Novel AML patient selection assay for AMV564, Amphivena's lead …
Dec 6, 2020 SOUTH SAN FRANCISCO, Calif., Dec. 6, 2020 /PRNewswire/ --Amphivena Therapeutics, a clinical-stage oncology company focused on developing immunotherapeutics …See details»
Amphivena Therapeutics - Updates, News, Events, Signals & Triggers
Amphivena Therapeutics is focused on developing biologics for immuno-oncology, specifically targeting acute myeloid leukemia (AML) and solid tumors. Their research includes methods …See details»